Picture of Bioatla logo

BCAB — Bioatla News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bioatla Inc reports results for the quarter ended in March - Earnings Summary

* Bioatla Inc  BCAB.OQ  reported a quarterly adjusted loss of 56
cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 52 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Bioatla Inc's reported EPS for the quarter was a loss of 56
cents​.
* The mean earnings estimate of analysts had risen by about 5.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Bioatla Inc shares had fallen by 8.2% this quarter and
gained 37.3% so far this year.
* The company reported a quarterly loss of $18.7 million.
* Wall Street's median 12-month price target for Bioatla Inc is
$75.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 13 at 02:35 a.m. GMT.
​All figures in US dollars

Recent news on Bioatla

See all news